BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2414396)

  • 1. Effect of mutation in immunodominant neutralization epitopes on the antigenicity of rotavirus SA-11.
    Knowlton DR; Ward RL
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2375-81. PubMed ID: 2414396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic reassortment between two human rotaviruses having different serotype and subgroup specificities.
    Urasawa S; Urasawa T; Taniguchi K
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1551-9. PubMed ID: 2426394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus isolate WI61 representing a presumptive new human serotype.
    Clark HF; Hoshino Y; Bell LM; Groff J; Hess G; Bachman P; Offit PA
    J Clin Microbiol; 1987 Sep; 25(9):1757-62. PubMed ID: 2443534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.
    Hoshino Y; Wyatt RG; Greenberg HB; Flores J; Kapikian AZ
    J Infect Dis; 1984 May; 149(5):694-702. PubMed ID: 6202807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominant neutralizing antigens depend on the virus strain during a primary immune response in calves to bovine rotaviruses.
    Xu Z; Hardy ME; Williams JD; Woode GN; Ramig RF
    Vet Microbiol; 1993 May; 35(1-2):33-43. PubMed ID: 8395744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.
    Ciarlet M; Hidalgo M; Gorziglia M; Liprandi F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1867-73. PubMed ID: 7519247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
    Kobayashi N; Taniguchi K; Urasawa S
    Arch Virol; 1991; 117(1-2):73-84. PubMed ID: 1706592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the two rotavirus genes determining neutralization specificities.
    Offit PA; Blavat G
    J Virol; 1986 Jan; 57(1):376-8. PubMed ID: 3001359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic relationships between rotaviruses from different species as studied by neutralization and immunofluorescence.
    Sato K; Inaba Y; Miura Y; Tokuhisa S; Matumoto M
    Arch Virol; 1982; 73(1):45-50. PubMed ID: 6181760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
    Coulson BS; Tursi JM; McAdam WJ; Bishop RF
    Virology; 1986 Oct; 154(2):302-12. PubMed ID: 2429439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of antigenic sites involved in serotype-cross-reactive neutralization on group A rotavirus outercapsid glycoprotein VP7.
    Hoshino Y; Nishikawa K; Benfield DA; Gorziglia M
    Virology; 1994 Feb; 199(1):233-7. PubMed ID: 8116249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
    Kobayashi N; Taniguchi K; Urasawa S
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.
    Padilla-Noriega L; Werner-Eckert R; Mackow ER; Gorziglia M; Larralde G; Taniguchi K; Greenberg HB
    J Clin Microbiol; 1993 Mar; 31(3):622-8. PubMed ID: 7681440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of four VP4 serological types (P serotypes) of bovine rotavirus using viral reassortants.
    Snodgrass DR; Hoshino Y; Fitzgerald TA; Smith M; Browning GF; Gorziglia M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2319-25. PubMed ID: 1328488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the neutralization epitopes on human rotavirus VP7 recognized by monotype-specific monoclonal antibodies.
    Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1855-61. PubMed ID: 1714939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.
    Taniguchi K; Hoshino Y; Nishikawa K; Green KY; Maloy WL; Morita Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M
    J Virol; 1988 Jun; 62(6):1870-4. PubMed ID: 2452893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotyping of cytopathic rotavirus strains isolated from calves].
    Georgiev GK; Kharalambiev KhE
    Vet Med Nauki; 1985; 22(8):7-12. PubMed ID: 3002007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cattle develop neutralizing antibodies to rotavirus serotypes which could not be isolated from faeces of symptomatic calves.
    Brüssow H; Eichhorn W; Rohwedder A; Snodgrass D; Sidoti J
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1559-67. PubMed ID: 1649894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.